PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

FedEx Obtains CEIV Pharma certification

FedEx Global Healthcare has obtained IATA’s Centre of Excellence for Independent Validators (CEIV) Pharma certification for its pharmaceutical logistics operations.

This certificate recognises FedEx’s efforts to maintain a quality management system and its ability to deliver end-to-end logistic services in compliance with the increasingly complex and highly regulated pharmaceutical industry.

“This certification illustrates FedEx’s unwavering dedication to excellence in pharmaceutical logistics,” said Nick Gennari, president of global healthcare and commercial sales.

“This pioneering, network-wide approach to quality showcases our commitment to complying with the highest standards in the industry for the transportation and handling of global pharmaceutical products.

“With over 90% of our global healthcare volume moving through facilities that are now CEIV Pharma-certified, we are providing our customers with outstanding quality solutions in the global pharma air space.”

“The pharmaceutical industry relies on air transport for its speed and efficiency in ensuring high-value, time-sensitive, temperature-controlled products such as vaccines or medication,” said Frederic Leger, IATA’s senior vice president commercial products and services.

“As global supply chains become more complex, the need for consistent, trusted standards is greater than ever for the safety of the end consumers. We are pleased to see FedEx Global Healthcare certify additional facilities with CEIV Pharma, the industry’s trusted mark of quality and excellence in the handling of pharmaceuticals.”

FedEx’s Memphis (MEM) and Indianapolis (IND) hubs were individually CEIV Pharma-certified in 2024, along with ramps in San Juan (SJU) and Aguadilla (BQN), Puerto Rico.

In addition to the new corporate CEIV certificate, FedEx Global Healthcare has also announced 15 new CEIV Pharma certified facilities.

These include Cologne, Germany (CGN), Fort Worth, Texas (AFW), Frankfurt, Germany (FRA), Greensboro, North Carolina (GSO), Guangzhou, China (CAN), Liege, Belgium (LGG), Los Angeles, California (LAX), Miami, Florida (MIA), Milan, Italy (MXP), Newark, New Jersey (EWR), Oakland, California (OAK), Osaka, Japan (KIX), Paris, France (CDG), San Jose, Costa Rica (SJO) and Santo Domingo, Dominican Republic (SDQ).

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026